Taro Pharma has reached a settlement agreement with the US Department of Justice, Antitrust and Civil divisions to pay more than $200 million to settle the generic drug price fixing allegations
The bids for these contracts were submitted in January this year and opened in March.
Wood suggests that moratorium could trigger a consumer lending non-performing loans (NPL) cycle
Here's a list of stocks that may trade actively in today's trading session.
Today, a total of 71 companies including ITC, Asian Paints, and Ambuja Cements are scheduled to announce their quarterly results
A more optimistic estimate by analysts at Nirmal Bang Institutional Equities pegs the profit at Rs 4,016.4 crore, up a whopping 110.5 per cent YoY and 228.8 per cent QoQ
In a Q&A, Sailesh Raj Bhan says mid and small-caps look attractive from a 3-5 year perspective; bets on two-wheelers, pharma, telecom, utilities
While Q2 will reflect the real asset quality picture, focus on non-discretionary spends, strong customer sourcing support to aid business
IRDAI said any transfer of shares beyond the stipulated threshold limits without the prior approval of the authority will attract appropriate regulatory and legal action
Under market norms, listed companies need to use a trading window to monitor transactions by designated persons in a bid to prevent insider trading
The S&P BSE Sensex surged 269 points or 0.71 per cent to settle at 38,140 levels while NSE's Nifty ended at 11,215, up 83 points
All that happened in the markets today
In the last one week, the stock of RIL has outperformed the market by surging 12 per cent, as compared to nearly 5 per cent rise in the S&P BSE Sensex.
Impact of the lockdown of manufacturing facilities, cigarette inventory levels, guidance on price and volume, and alternate distribution channels are among the key monitorables
On June 12, the company's board approved the stock split in the ratio of 1:10
The bid project cost is Rs 4,167.70 crore with completion period of 48 months and maintenance period of 10 years
Analysts expect ITC's FMCG business to do well on the back of both foods and personal care segments.
L&T booked orders worth Rs 23,574 crore - a 39 per cent drop from the Rs 38,700 crore in Q1FY20.
The bank had fixed a price band of Rs 12-13 for the public issue and raised nearly Rs 4,100 crore through anchor allotments by issuing shares at price of Rs 12 per share
The stock rallied 64% to Rs 698 against issue price of Rs 425 on the BSE.